RecruitingNot ApplicableNCT06588101

Clinical Trial Recruitment and Retention Strategies for Family Members in the ICU

Clinical Trial Recruitment and Retention Strategies for Family Members in the Intensive Care Unit: A Study Within A Trial Randomized Design


Sponsor

Lady Davis Institute

Enrollment

160 participants

Start Date

May 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

There is a need to identify strategies that improve the conduct of clinical trials involving family members of intensive care unit (ICU) patients. The purpose of the present study is to evaluate recruitment and retention strategies for clinical trials involving family members of ICU patients. 4 strategies (2 recruitment and 2 retention) will be tested. Investigators will integrate the strategies into three existing studies that involve family members of ICU patients. Participants will be randomized using a 2x2 factorial design. The co-primary outcomes are recruitment percentage (participants enrolled/participants approached) and retention percentage (participants completing follow-up/participants enrolled).


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Has family member admitted to an intensive care unit.
  • Expected hospital stay \> 48 hours
  • Able to participate in English or French

Exclusion Criteria2

  • Has another family member participating in the trial
  • Repeat admissions within the study period

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERWritten informed consent with infographic

Potential participants are provided a visual infographic depicting the key elements of the written consent form in addition to the standard written consent form.

OTHERCompensation

Potential participants are provided an e-gift card to Amazon or Second Cup as a reward for completing the enrollment questionnaire.


Locations(1)

Jewish General Hospital

Montreal, Quebec, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06588101


Related Trials